7 years ago
1
Mylan faces federal antitrust investigator in EpiPen business
Federal antitrust regulators are eyeing big drugmaker Mylan's EpiPen business, the company said this week. Mylan, in a statement, said the Federal Trade Commission asked it "months ago" for information about its anti-allergy EpiPen "as part of a preliminary investigation." The disclosure comes nearly five months after two United States senators asked the FTC to investigate whether Mylan violated antitrust laws to protect the auto-injector EpiPen from competition.
Continue Reading
http://www.nbcnews.com
Join the Discussion
Good news: They may get a big fine.
Bad news: it will amount to 10% of their profits from the price gouging.